← Back to Calendar
Live Company Data
NCM
Updated
just now
· Data: FMP
Current Price
$18.53
+28.32%
+$4.09 today
Day: $16.97 – $19.10
52-Week Range
Current price is at 35% of 52-week range
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Q1 2026 earnings + veligrotug PDUFA preparation + VRDN-003 Phase 3 update
Key Notes
Q1 2026 earnings expected ~May 6, 2026. Key updates: commercial readiness for veligrotug (PDUFA June 30, 2026 in TED); REVEAL-1 and REVEAL-2 Phase 3 data for subQ VRDN-003; cash position ($889M potential capital financing). Multiple near-term catalysts make VRDN a closely watched sub-$7B cap biotech.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.